Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ligand Pharmaceuticals (LGND) Q2 2017 Earnings
LGND
9
May
Confirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
0.39
0.68
0.96
1.25
Details
Expected EPS
0.63
Actual EPS
0.57
Surprise EPS
-0.06
Surprise Percent
+9.52%
Description
Ligand Pharmaceuticals (LGND) has reported earnings of 0.57 per share for Q2 2017.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist